Oxervate Effective at Managing Hard-to-treat NK, Case Study Reports

Oxervate Effective at Managing Hard-to-treat NK, Case Study Reports

283062

Oxervate Effective at Managing Hard-to-treat NK, Case Study Reports

Adding Oxervate (cenegermin) eye drops to conventional treatment approaches may successfully manage hard-to-treat neurotrophic keratitis (NK) associated with eye surgery and persistent infections, a case study suggests. This case adds to the increasing number of reports providing real-world evidence of Oxervate’s effectiveness in the treatment of NK, supporting its use in this patient population. The case study, “A Novel Treatment for Neurotrophic Corneal Ulcer Using Topical Cenegermin (OXERVATE) Containing Recombinant Human Nerve Growth Factor,” was…

You must be logged in to read/download the full post.